Assessment of Hepatic and Pancreatic Iron Overload in Pediatric Beta-thalassemic Major Patients by T2* Weighted Gradient Echo Magnetic Resonance Imaging

Overview

Journal ISRN Hematol

Specialty Hematology

Date 2013 Apr 23

PMID 23606980

Citations 7

Authors

Doaa Mohammed Youssef

Faten Fawzy Mohammad

Ayman Ahmed Fathy

Maha Aly Abdelbasset

Affiliations

Soon will be listed here.

Abstract

Background. MRI has emerged for the noninvasive assessment of iron overload in various tissues. The aim of this paper is to evaluate hepatic and pancreatic iron overload by T2(∗) weighted gradient echo MRI in young beta-thalassemia major patients and to correlate it with glucose disturbance and postsplenectomy status. Subjects and Methods. 50 thalassemic patients, in addition to 15 healthy controls. All patients underwent clinical assessment and laboratory investigations. Out of 50 thalassemic patients, 37 patients were splenectomized. MRI was performed for all subjects. Results. All patients showed significant reduction in the signal intensity of the liver and the pancreas on T2(∗)GRD compared to controls, thalassemic patients who had abnormal glucose tolerance; diabetic and impaired glucose tolerance patients displayed a higher degree of pancreatic and hepatic siderosis and more T2(∗) drop in their signal intensity than those with normal blood sugar level. Splenectomized thalassemic patients had significantly lower signal intensity of the liver and pancreas compared to nonsplenectomized patients. Conclusion. T2(∗) gradient echo MRI is noninvasive highly sensitive method in assessing hepatic and pancreatic iron overload in thalassemic patients, more evident in patients with abnormal glucose tolerance, and is accelerated in thalassemic splenectomized patients.

Citing Articles

Correlation of Magnesium Level with Cardiac and Hepatic Hemosiderosis Measured by T2*MRI Technique and Age in Patients with Thalassemia Major.

Ghasemi A, Ghaffari K, Hoseini F, Eghbali A, Sajadei N, Falahati V Int J Hematol Oncol Stem Cell Res. 2023; 17(4):224-230.

PMID: 38076774 PMC: 10700100. DOI: 10.18502/ijhoscr.v17i4.13912.

Magnetic resonance imaging T2 of the pancreas value using an online software tool and correlate with T2 value of myocardium and liver among patients with transfusion-dependent thalassemia major.

Hoe H, Git K, Loh C, Latiff Z, Hong J, Hamid H Front Radiol. 2023; 2:943102.

PMID: 37492672 PMC: 10365003. DOI: 10.3389/fradi.2022.943102.

The Pancreatic changes affecting glucose homeostasis in transfusion dependent β- thalassemia (TDT): a short review.

De Sanctis V, Soliman A, Tzoulis P, Daar S, Fiscina B, Kattamis C Acta Biomed. 2021; 92(3):e2021232.

PMID: 34212898 PMC: 8343719. DOI: 10.23750/abm.v92i3.11685.

Glucose dysregulation in patients with iron overload: is there a relationship with quantitative pancreas and liver iron and fat content measured by MRI?.

Shur J, Kannengiesser S, Menezes R, Ward R, Kuo K, Jhaveri K Eur Radiol. 2019; 30(3):1616-1623.

PMID: 31712958 DOI: 10.1007/s00330-019-06487-z.

Effective method of evaluating myocardial iron concentration in pediatric patients with thalassemia major.

Khaled A, Ezzat D, Salem H, Seif H, Rabee H J Blood Med. 2019; 10:227-233.

PMID: 31372080 PMC: 6636185. DOI: 10.2147/JBM.S204848.

References

Wood J, Ghugre N . Magnetic resonance imaging assessment of excess iron in thalassemia, sickle cell disease and other iron overload diseases. Hemoglobin. 2008; 32(1-2):85-96. PMC: 2884397. DOI: 10.1080/03630260701699912. View

Noetzli L, Papudesi J, Coates T, Wood J . Pancreatic iron loading predicts cardiac iron loading in thalassemia major. Blood. 2009; 114(19):4021-6. PMC: 2774543. DOI: 10.1182/blood-2009-06-225615. View

Argyropoulou M, Astrakas L . MRI evaluation of tissue iron burden in patients with beta-thalassaemia major. Pediatr Radiol. 2007; 37(12):1191-200. PMC: 2292491. DOI: 10.1007/s00247-007-0567-1. View

Alustiza J, Castiella A, de Juan M, Emparanza J, Artetxe J, Uranga M . Iron overload in the liver diagnostic and quantification. Eur J Radiol. 2006; 61(3):499-506. DOI: 10.1016/j.ejrad.2006.11.012. View

Westphalen A, Qayyum A, Yeh B, Merriman R, Lee J, Lamba A . Liver fat: effect of hepatic iron deposition on evaluation with opposed-phase MR imaging. Radiology. 2007; 242(2):450-5. DOI: 10.1148/radiol.2422052024. View

Wood J, Enriquez C, Ghugre N, Tyzka J, Carson S, Nelson M . MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood. 2005; 106(4):1460-5. PMC: 1895207. DOI: 10.1182/blood-2004-10-3982. View

Kattamis C, Ladis V, Tsoussis D, Kaloumenou I, Theodoridis C . Evolution of glucose intolerance and diabetes in transfused patients with thalassemia. Pediatr Endocrinol Rev. 2006; 2 Suppl 2:267-71. View

Luk C, Ling S, Chik K, Yuen H, Li C, Shing M . Morbidity and mortality patterns of thalassaemia major patients in Hong Kong: retrospective study. Hong Kong Med J. 2002; 8(4):255-60. View

Queiroz-Andrade M, Blasbalg R, Ortega C, Rodstein M, Baroni R, Rocha M . MR imaging findings of iron overload. Radiographics. 2009; 29(6):1575-89. DOI: 10.1148/rg.296095511. View

10.

Angelucci E, Brittenham G, McLaren C, Ripalti M, Baronciani D, Giardini C . Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med. 2000; 343(5):327-31. DOI: 10.1056/NEJM200008033430503. View

11.

Matter R, Allam K, Sadony A . Gradient-echo magnetic resonance imaging study of pancreatic iron overload in young Egyptian beta-thalassemia major patients and effect of splenectomy. Diabetol Metab Syndr. 2010; 2:23. PMC: 2873247. DOI: 10.1186/1758-5996-2-23. View

12.

Monge L, Pinach S, Caramellino L, Bertero M, Dallomo A, CARTA Q . The possible role of autoimmunity in the pathogenesis of diabetes in B-thalassemia major. Diabetes Metab. 2001; 27(2 Pt 1):149-54. View

13.

Rund D, Rachmilewitz E . Beta-thalassemia. N Engl J Med. 2005; 353(11):1135-46. DOI: 10.1056/NEJMra050436. View

14.

Tziomalos K, Perifanis V . Liver iron content determination by magnetic resonance imaging. World J Gastroenterol. 2010; 16(13):1587-97. PMC: 2848367. DOI: 10.3748/wjg.v16.i13.1587. View

15.

Anderson L, Holden S, Davis B, Prescott E, Charrier C, Bunce N . Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2002; 22(23):2171-9. DOI: 10.1053/euhj.2001.2822. View

16.

Hershko C, Link G, Konijn A, Cabantchik Z . Objectives and mechanism of iron chelation therapy. Ann N Y Acad Sci. 2005; 1054:124-35. DOI: 10.1196/annals.1345.015. View

17.

Papakonstantinou O, Ladis V, Kostaridou S, Maris T, Berdousi H, Kattamis C . The pancreas in beta-thalassemia major: MR imaging features and correlation with iron stores and glucose disturbances. Eur Radiol. 2006; 17(6):1535-43. DOI: 10.1007/s00330-006-0507-8. View

18.

Chern J, Lin K, Lu M, Lin D, Lin K, Chen J . Abnormal glucose tolerance in transfusion-dependent beta-thalassemic patients. Diabetes Care. 2001; 24(5):850-4. DOI: 10.2337/diacare.24.5.850. View

19.

Angelucci E, Baronciani D, Lucarelli G, Baldassarri M, Galimberti M, Giardini C . Needle liver biopsy in thalassaemia: analyses of diagnostic accuracy and safety in 1184 consecutive biopsies. Br J Haematol. 1995; 89(4):757-61. DOI: 10.1111/j.1365-2141.1995.tb08412.x. View

20.

Cario H, Holl R, Debatin K, Kohne E . Insulin sensitivity and beta-cell secretion in thalassaemia major with secondary haemochromatosis: assessment by oral glucose tolerance test. Eur J Pediatr. 2003; 162(3):139-146. DOI: 10.1007/s00431-002-1121-7. View